TG Therapeutics Inc. is a commercial-stage biopharmaceutical company centered on the advancement of innovative treatments for B-cell diseases. TG Therapeutics Inc. was established on May 18, 1993, by Michael Sean Weiss and Laurence H. Shaw. Michael S. Weiss also works as the CEO of TG Therapeutics. The main headquarter of TG Therapeutics Inc. is located in New York, United States. The services or specialties of TG Therapeutics Inc. are biotechnology, hematological malignancies, and non-Hodgkin’s lymphoma. The mission of TG Therapeutics Inc. is to advance novel treatments for B-cells & B-cells diseases. TG Therapeutics Inc. always looking for passionate, hardworking & talented employees, they offer multiple job opportunities for all regardless of race, color, age, religion, marital status, and national origin. TG Therapeutics Inc. provides employee benefits to appreciate their employees like competitive wages, professional development programs, and many others.
See what companies are similar to TG Therapeutics Inc
You comment as